Miniatura

Fitxers

696070.pdf (803.42 KB)

Tipus de document

Article

Versió

Versió acceptada

Data de publicació

2018-01-01

Tots els drets reservats

Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/178169

Association between chronic immune-mediated inflammatory diseases and cardiovascular risk

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1136/heartjnl-2017-311279

Resum

Objective: To examine the association between chronic immune-mediated diseases (rheumatoid arthritis, systemic lupus erythematosus or the following chronic immune-mediated inflammatory diagnoses groups: inflammatory bowel diseases, inflammatory polyarthropathies, systemic connective tissue disorders and spondylopathies) and the 6-year coronary artery disease, stroke, cardiovascular disease incidence and overall mortality; and to estimate the population attributable fractions for all four end-points for each chronic immune-mediated inflammatory disease. Methods: Cohort study of individuals aged 35-85 years, with no history of cardiovascular disease from Catalonia (Spain). The coded diagnoses of chronic immune-mediated diseases and cardiovascular diseases were ascertained and registered using validated codes, and date of death was obtained from administrative data. Cox regression models for each outcome according to exposure were fitted to estimate HRs in two models 1 : after adjustment for sex, age, cardiovascular risk factors and 2 further adjusted for drug use. Population attributable fractions were estimated for each exposure. Results: Data were collected from 991 546 participants. The risk of cardiovascular disease was increased in systemic connective tissue disorders (model 1: HR=1.38 (95% CI 1.21 to 1.57) and model 2: HR=1.31 (95% CI 1.15 to 1.49)), rheumatoid arthritis (HR=1.43 (95% CI 1.26 to 1.62) and HR=1.31 (95% CI 1.15 to 1.49)) and inflammatory bowel diseases (HR=1.18 (95% CI 1.06 to 1.32) and HR=1.12 (95% CI 1.01 to 1.25)). The effect of anti-inflammatory treatment was significant in all instances (HR=1.50 (95% CI 1.24 to 1.81); HR=1.47 (95% CI 1.23 to 1.75); HR=1.43 (95% CI 1.19 to 1.73), respectively). The population attributable fractions for all three disorders were 13.4%, 15.7% and 10.7%, respectively. Conclusion: Systemic connective tissue disorders and rheumatoid arthritis conferred the highest cardiovascular risk and population impact, followed by inflammatory bowel diseases.

Matèries

Malalties cardiovasculars, Inflamació

Matèries (anglès)

Cardiovascular diseases, Inflammation

Citació

Col·leccions

Articles publicats en revistes (Medicina)

Citació

BAENA DÍEZ, José miguel, GARCÍA GIL, Maria, COMAS CUFÍ, Marc, RAMOS, Rafel, PRIETO ALHAMBRA, Daniel, SALVADOR GONZÁLEZ, Betlem, ELOSUA, Roberto, DEGANO, Irene r., PEÑAFIEL, Judith, GRAU, Maria. Association between chronic immune-mediated inflammatory diseases and cardiovascular risk. _Heart_. 2018. Vol. 104, núm. 2, pàgs. 119-126. [consulta: 24 de gener de 2026]. ISSN: 1355-6037. [Disponible a: https://hdl.handle.net/2445/178169]

Exportar metadades

JSON - METS

Compartir registre